Manufacturers Life Insurance Company, The Tcr2 Therapeutics Inc. Transaction History

Manufacturers Life Insurance Company, The

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 20, 2022	SELL	$2.4 - $4.71 $35,167 - $69,015	-14,653 Closed	0 $0
Q4 2021 Feb 16, 2022	SELL	$4.58 - $8.34 $26,330 - $47,946	-5,749 Reduced 28.18%	14,653 $68,000
Q3 2021 Nov 12, 2021	BUY	$8.44 - $18.35 $16,162 - $35,140	1,915 Added 10.36%	20,402 $174,000
Q2 2021 Aug 12, 2021	BUY	$16.41 - $24.71 $22,251 - $33,506	1,356 Added 7.92%	18,487 $303,000
Q1 2021 May 03, 2021	BUY	$20.38 - $34.07 $31,099 - $51,990	1,526 Added 9.78%	17,131 $378,000
Q4 2020 Feb 12, 2021	BUY	$19.0 - $32.63 $19,038 - $32,695	1,002 Added 6.86%	15,605 $483,000
Q3 2020 Nov 09, 2020	BUY	$13.1 - $20.69 $51,862 - $81,911	3,959 Added 37.19%	14,603 $297,000
Q2 2020 Aug 10, 2020	BUY	$6.51 - $16.85 $69,292 - $179,351	10,644 New	10,644 $166,000

Ticker TCRR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,606,400
Description
TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical tria...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.